Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2026-02-03 @ 10:41 AM
Study NCT ID:
NCT03870334
Status:
TERMINATED
Last Update Posted:
2023-12-04
First Post:
2019-03-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease
Sponsor:
NImmune Biopharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BT-11-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None